Veeva introduces trial startup software; Medivo gains access to Quest test data;

> Veeva Systems ($VEEV) introduced software to support the startup of clinical trials. Release

> Medivo struck a deal to access Quest Diagnostics' ($DGX) database of 20 billion de-identified test results. Item

> STAT profiled the work of a pair of genomics pioneers, J. Craig Venter and Feng Zhang. Feature | More

> Qiagen ($QGEN) posted data on the effectiveness of its GeneReader NGS System at detecting gene variants. News

> WIRED and Nature News looked at the trend for Silicon Valley VCs to invest in synthetic biology startups. Article | More

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.